The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xtex 250 mg /5 ml oral solution

Rowa Pharmaceuticals LimitedPA0074/071/001

Main Information

Trade NameXtex 250 mg /5 ml oral solution
Active SubstancesCarbocisteine
Dosage FormOral solution
Licence HolderRowa Pharmaceuticals Limited
Licence NumberPA0074/071/001

Group Information

ATC CodeR05CB Mucolytics
R05CB03 carbocisteine


License statusAuthorised
Licence Issued14/07/2017
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back